MoneyWorks4Me

Smruthi Organics - Quaterly Results

06 May 2024 Evaluate
A fair growth of 7.83% in the revenue at Rs. 396.58 millions was reported in the March 2024 quarter as compared to Rs. 367.77 millions during year-ago period.Net Profit witnessed a 120.29% growth almost the double from Rs. 6.90 millions to Rs. 15.20  millions  of same quarter last year.Operating profit for the quarter ended March 2024 rose to 41.46 millions as compared to 22.96 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 396.58 367.77 7.83 1276.43 1410.41 -9.50 1276.43 1410.41 -9.50
Other Income 0.61 0.53 15.09 0.76 1.07 -28.97 0.76 1.07 -28.97
PBIDT 41.46 22.96 80.57 120.31 98.87 21.69 120.31 98.87 21.69
Interest 3.72 2.50 48.80 14.08 8.22 71.29 14.08 8.22 71.29
PBDT 37.74 20.46 84.46 106.23 90.65 17.19 106.23 90.65 17.19
Depreciation 15.87 12.39 28.09 56.53 45.72 23.64 56.53 45.72 23.64
PBT 21.87 8.07 171.00 49.70 44.93 10.62 49.70 44.93 10.62
TAX 6.67 1.17 470.09 13.79 3.63 279.89 13.79 3.63 279.89
Deferred Tax 0.00 -2.34 -100.00 -2.27 -10.97 -79.31 -2.27 -10.97 -79.31
PAT 15.20 6.90 120.29 35.91 41.30 -13.05 35.91 41.30 -13.05
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 10.45 6.24 67.46 9.43 7.01 34.46 9.43 7.01 34.46
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..